Insider · CIK 0002047603
Kamran Ziaee
Files at ED (CONSOLIDATED EDISON INC). First filing -, latest -.
In brief
Kamran Ziaee files SEC Form 4 as officer at ED (CONSOLIDATED EDISON INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kamran Ziaee has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | ED CONSOLIDATED EDISON INC | AGrant or award Performance Unitsderivative | +7,800 | - | - | 7,800 | Feb 20, 2026 |
| Feb 18, 2026 | ED CONSOLIDATED EDISON INC | AGrant or award Time-Based Restricted Stock Unitsderivative | +3,400 | - | - | 3,400 | Feb 20, 2026 |
| Feb 19, 2025 | ED CONSOLIDATED EDISON INC | AGrant or award Performance Unitsderivative | +9,000 | - | - | 9,000 | Feb 21, 2025 |
| Feb 19, 2025 | ED CONSOLIDATED EDISON INC | AGrant or award Time - Based Restricted Stock Unitsderivative | +3,900 | - | - | 3,900 | Feb 21, 2025 |
Questions about Kamran Ziaee
Answered from the filings on this page, as of the latest one.
Is Kamran Ziaee buying or selling?
Kamran Ziaee has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kamran Ziaee's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kamran Ziaee has 0.
Where does Kamran Ziaee file Form 4?
Kamran Ziaee has filed Form 4 at ED (CONSOLIDATED EDISON INC) as SVP & Ch.Information Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.